Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-24-001993

President and CEO acquired 163,890 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mack David Henry President and CEO 2024-01-18 Grant or award +163,890 442,460 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Mack David Henry President and CEO 2024-01-18 Grant or award · Employee Stock Option (right to buy) +519,915 519,915 D: show line 2 in the form
Loading xslF345X05/doc4.xml…